Keyword: generic competition
News
30.06.2014
- The European Medicine Agency (EMA) has recommended approval of Abasria, Eli Lilly's biosimilar version of Sanofi's insulin glargine sold as Lantus. This means that the French...
News
14.05.2013
- The French Competition Authority fined drugmaker Sanofi €40.6 million ($52.7 million) on Tuesday for "disparaging" generic competition to its Plavix blood thinner. The decision on...
News
29.01.2013
- Eli Lilly said on Tuesday that fourth-quarter profit fell as competition from generic drugs, particularly for its once top-selling schizophrenia drug Zyprexa, drove revenue lower...
News
04.01.2013
- Eli Lilly said on Friday it expects profit in 2013 to increase by more than Wall Street had been forecasting, primarily due to cost controls and improved productivity. Lilly, whose...
News
03.10.2012
- Drugmakers Sanofi and Bristol-Myers Squibb plan to revamp their 15-year-old alliance from Jan. 1 in response to lost exclusivity on two key drugs and the arrival of generic...
News
20.09.2012
- Pressure from governments to lower drug prices risks undermining medical innovation, Bayer's chief executive Marjin Dekkers said on Wednesday, echoing complaints of other drug...
News
03.08.2012
- Global biotech merger volume has reached levels not seen in four years as big pharmaceutical companies pursue deals to get access to new drugs, with bankers saying therapeutic...
News
31.07.2012
- Pfizer reported higher-than-expected quarterly earnings, helped by cuts in research spending and other costs, and affirmed its 2012 profit forecast despite the negative impact of...
